Mark Dodds is the new Chair

Author: CIM FDA

At the Annual Review on 29 November we will formally welcome Mark Dodds to the position of the Chair of the FDA Group.

 Mark has been involved with the FDA Group for a number of years and agreed to take on this role earlier on in the summer. Mark has a number of good ideas as to how the Group can keep moving forward and will bring a good deal of experience to the role, not least, gained from his position as Marketing Manager at Roythornes, one of the leading agricultural and food sector law firms in the UK.

As part of our deliberate policy of rotating members on and off the FDA board, in order to keep the organisation of our events fresh and vibrant. At the annual review will also see 2 long standing FDA board members stand down and 2 new ones elected. Full details will be announced on the evening and you can view the new committee members online.